NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 25 04:00PM ET
17.91
Dollar change
-1.36
Percentage change
-7.06
%
IndexRUT P/E- EPS (ttm)-0.90 Insider Own81.32% Shs Outstand65.93M Perf Week0.96%
Market Cap1.20B Forward P/E- EPS next Y- Insider Trans0.20% Shs Float12.56M Perf Month13.35%
Income-53.59M PEG- EPS next Q- Inst Own8.91% Short Float18.75% Perf Quarter-1.16%
Sales0.00M P/S- EPS this Y- Inst Trans5.57% Short Ratio12.49 Perf Half Y1.59%
Book/sh1.74 P/B10.28 EPS next Y- ROA-55.00% Short Interest2.35M Perf Year161.08%
Cash/sh1.75 P/C10.21 EPS next 5Y- ROE-67.31% 52W Range6.59 - 25.00 Perf YTD2.87%
Dividend Est.- P/FCF- EPS past 5Y16.53% ROI-43.78% 52W High-28.36% Beta1.55
Dividend TTM- Quick Ratio11.88 Sales past 5Y-30.13% Gross Margin- 52W Low171.57% ATR (14)1.25
Dividend Ex-Date- Current Ratio11.88 EPS Y/Y TTM-1.00% Oper. Margin- RSI (14)55.46 Volatility7.01% 8.07%
Employees75 Debt/Eq0.08 Sales Y/Y TTM-100.00% Profit Margin- Recom3.00 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q-44.16% Payout- Rel Volume1.01 Prev Close19.27
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsMay 08 AMC Avg Volume188.59K Price17.91
SMA208.25% SMA503.35% SMA2000.61% Trades Volume189,694 Change-7.06%
Date Action Analyst Rating Change Price Target Change
Jul-27-21Initiated Stephens Overweight $28
Mar-11-21Initiated Maxim Group Buy $40
Jan-26-21Reiterated H.C. Wainwright Buy $16 → $40
May-12-20Upgrade H.C. Wainwright Neutral → Buy $6 → $16
Feb-14-20Downgrade H.C. Wainwright Buy → Neutral $26 → $6
Feb-25-19Initiated H.C. Wainwright Buy $27
Apr-25-25 04:05PM
Apr-24-25 04:05PM
Apr-23-25 07:00AM
Apr-10-25 01:00PM
10:36AM
08:10AM Loading…
Mar-28-25 08:10AM
03:03AM
Mar-27-25 07:46PM
04:05PM
Mar-26-25 04:05PM
Mar-07-25 08:00AM
Mar-04-25 08:00AM
Feb-20-25 04:05PM
Feb-05-25 09:42AM
Feb-04-25 08:00AM
08:00AM Loading…
Jan-30-25 08:00AM
Jan-21-25 01:03PM
07:00AM
Jan-13-25 07:00AM
Jan-10-25 08:00AM
Jan-03-25 09:00AM
Dec-23-24 04:30PM
Dec-19-24 08:00AM
Dec-17-24 08:00AM
Oct-31-24 02:25PM
01:58PM
05:01AM
Oct-30-24 04:05PM
04:02PM
Oct-21-24 08:00AM
07:55AM Loading…
Aug-21-24 07:55AM
Aug-13-24 12:38PM
Aug-12-24 04:05PM
04:01PM
Aug-09-24 06:32AM
Aug-08-24 08:00AM
Aug-01-24 04:05PM
Jul-29-24 04:05PM
Jul-09-24 07:27AM
06:53AM
Jul-08-24 08:00AM
Jul-03-24 02:44PM
Jun-28-24 08:00AM
Jun-04-24 08:00AM
May-20-24 05:39PM
04:05PM
May-17-24 06:41AM
May-16-24 08:00AM
May-14-24 05:17PM
04:05PM
May-13-24 09:02AM
May-09-24 08:00AM
May-08-24 06:06AM
03:56AM
May-07-24 09:56PM
05:45PM
04:05PM
May-02-24 08:00AM
Apr-28-24 11:59AM
Apr-24-24 04:05PM
Apr-01-24 04:19PM
Mar-29-24 06:30AM
Mar-28-24 10:53PM
05:51PM
04:12PM
04:10PM
Mar-14-24 04:05PM
Mar-08-24 01:17PM
Feb-14-24 08:00AM
Jan-31-24 08:00AM
Jan-02-24 08:00AM
Dec-20-23 08:00AM
Nov-21-23 08:00AM
Nov-15-23 04:05PM
Nov-14-23 12:52PM
02:15AM
Nov-13-23 11:13AM
08:00AM
Nov-10-23 04:56PM
Oct-30-23 04:05PM
Oct-24-23 08:00AM
Oct-02-23 08:00AM
Sep-29-23 08:00AM
Sep-27-23 08:00AM
Sep-07-23 04:05PM
Aug-24-23 04:05PM
Aug-17-23 09:31AM
Aug-11-23 06:28AM
Aug-10-23 04:05PM
Jul-30-23 09:35AM
Jul-27-23 04:05PM
May-22-23 09:30AM
May-18-23 07:00AM
May-16-23 12:01PM
May-12-23 07:43AM
May-11-23 04:05PM
May-10-23 09:29AM
May-03-23 08:00AM
May-01-23 08:00AM
Apr-27-23 04:05PM
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barrett Burke ThomasFormer President and CEODec 11 '24Sale17.4250,000871,00063,172Dec 20 05:00 PM
DUGGAN ROBERT WDirectorDec 13 '24Buy17.1855,256949,29842,328,717Dec 17 08:02 PM
DUGGAN ROBERT WDirectorDec 12 '24Buy17.1345,404777,77142,273,461Dec 17 06:05 AM
DUGGAN ROBERT WDirectorDec 11 '24Buy17.3556,054972,34442,228,057Dec 13 07:30 PM
Barrett Burke ThomasPresident and CEOMay 20 '24Buy8.5610,00085,60010,000May 22 02:07 PM